MAP2K7 and melanoma: Inulin shows significant promise in the context of melanoma by enriching antitumor microbial populations and enhancing the therapeutic efficacy of MEK inhibitors, particularly in BRAF-mutant melanoma, a subtype characterized by aggressive cell growth and poor prognosis [1, 40].